# Eastern Co: financial statements, quarterly

EML · Nasdaq · CIK 31107 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/eml.md) · [Financials](/companies/eml/financials.md) · [Filings](/companies/eml/filings.md) · [Insiders](/companies/eml/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eml/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-28) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [62.0](/filings/0001654954-24-013767.md) | [52.4 d](/filings/0001654954-25-002610.md) | [64.6](/filings/0001654954-25-005148.md) | [72.6](/filings/0001654954-25-009068.md) | [71.3](/filings/0001654954-25-012582.md) | [66.7 d](/filings/0001654954-26-002506.md) | [63.3](/filings/0001654954-26-004741.md) | [70.2](/filings/0001654954-26-007478.md) | [55.3](/filings/0001654954-25-012582.md) | [57.5 d](/filings/0001654954-26-002506.md) | [59.7](/filings/0001654954-26-004741.md) | [61.8](/filings/0001654954-26-007478.md) |
| Cost of revenue | $m | [46.6](/filings/0001654954-24-013767.md) | [46.7 d](/filings/0001654954-25-002610.md) | [49.2](/filings/0001654954-25-005148.md) | [54.1](/filings/0001654954-25-009068.md) | [53.1](/filings/0001654954-25-012582.md) | [51.3 d](/filings/0001654954-26-002506.md) | [49.1](/filings/0001654954-26-004741.md) | [53.8](/filings/0001654954-26-007478.md) | [43.0](/filings/0001654954-25-012582.md) | [44.4 d](/filings/0001654954-26-002506.md) | [47.7](/filings/0001654954-26-004741.md) | [49.1](/filings/0001654954-26-007478.md) |
| Gross profit | $m | [15.4](/filings/0001654954-24-013767.md) | [17.1 d](/filings/0001654954-25-002610.md) | [15.5](/filings/0001654954-25-005148.md) | [18.5](/filings/0001654954-25-009068.md) | [18.2](/filings/0001654954-25-012582.md) | [15.4 d](/filings/0001654954-26-002506.md) | [14.2](/filings/0001654954-26-004741.md) | [16.4](/filings/0001654954-26-007478.md) | [12.4](/filings/0001654954-25-012582.md) | [13.1 d](/filings/0001654954-26-002506.md) | [11.9](/filings/0001654954-26-004741.md) | [12.8](/filings/0001654954-26-007478.md) |
| Research and development | $m | [1.4](/filings/0001654954-24-013767.md) | [1.3 d](/filings/0001654954-25-002610.md) | [1.4](/filings/0001654954-25-005148.md) | [1.3](/filings/0001654954-25-009068.md) | [1.1](/filings/0001654954-25-012582.md) | [1.1 d](/filings/0001654954-26-002506.md) | [1.1](/filings/0001654954-26-004741.md) | [1.0](/filings/0001654954-26-007478.md) | [1.0](/filings/0001654954-25-012582.md) | [0.9 d](/filings/0001654954-26-002506.md) | [1.0](/filings/0001654954-26-004741.md) | [1.0](/filings/0001654954-26-007478.md) |
| Selling, general and administrative | $m | [8.5](/filings/0001654954-24-013767.md) | [10.1 d](/filings/0001654954-25-002610.md) | [10.7](/filings/0001654954-25-005148.md) | [11.1](/filings/0001654954-25-009068.md) | [10.3](/filings/0001654954-25-012582.md) | [11.2 d](/filings/0001654954-26-002506.md) | [9.8](/filings/0001654954-26-004741.md) | [12.2](/filings/0001654954-26-007478.md) | [9.6](/filings/0001654954-25-012582.md) | [10.0 d](/filings/0001654954-26-002506.md) | [9.6](/filings/0001654954-26-004741.md) | [10.1](/filings/0001654954-26-007478.md) |
| Operating income | $m | [5.6](/filings/0001654954-24-013767.md) | [5.7 d](/filings/0001654954-25-002610.md) | [3.4](/filings/0001654954-25-005148.md) | [6.0](/filings/0001654954-25-009068.md) | [6.8](/filings/0001654954-25-012582.md) | [3.0 d](/filings/0001654954-26-002506.md) | [3.2](/filings/0001654954-26-004741.md) | [3.1](/filings/0001654954-26-007478.md) | [1.7](/filings/0001654954-25-012582.md) | [2.2 d](/filings/0001654954-26-002506.md) | [1.3](/filings/0001654954-26-004741.md) | [1.7](/filings/0001654954-26-007478.md) |
| Interest expense | $m | [0.9](/filings/0001654954-24-013767.md) | [0.7 d](/filings/0001654954-25-002610.md) | [0.7](/filings/0001654954-25-005148.md) | [0.7](/filings/0001654954-25-009068.md) | [0.7](/filings/0001654954-25-012582.md) | [0.7 d](/filings/0001654954-26-002506.md) | [0.6](/filings/0001654954-26-004741.md) | [0.6](/filings/0001654954-26-007478.md) | [0.7](/filings/0001654954-25-012582.md) | [0.7 d](/filings/0001654954-26-002506.md) | [0.5](/filings/0001654954-26-004741.md) | [0.6](/filings/0001654954-26-007478.md) |
| Income tax | $m | [1.1](/filings/0001654954-24-013767.md) | [0.7 d](/filings/0001654954-25-002610.md) | [0.6](/filings/0001654954-25-005148.md) | [1.2](/filings/0001654954-25-009068.md) | [1.3](/filings/0001654954-25-012582.md) | [0.5 d](/filings/0001654954-26-002506.md) | [0.5](/filings/0001654954-26-004741.md) | [0.5](/filings/0001654954-26-007478.md) | [0.3](/filings/0001654954-25-012582.md) | [0.1 d](/filings/0001654954-26-002506.md) | [0.2](/filings/0001654954-26-004741.md) | [1.9](/filings/0001654954-26-007478.md) |
| Net income | $m | [3.1](/filings/0001654954-24-013767.md) | [3.5 d](/filings/0001654954-25-002610.md) | [1.9](/filings/0001654954-25-005148.md) | [3.5](/filings/0001654954-25-009068.md) | [(15.3)](/filings/0001654954-25-012582.md) | [1.3 d](/filings/0001654954-26-002506.md) | [1.9](/filings/0001654954-26-004741.md) | [3.4](/filings/0001654954-26-007478.md) | [0.6](/filings/0001654954-25-012582.md) | [1.2 d](/filings/0001654954-26-002506.md) | [0.6](/filings/0001654954-26-004741.md) | [5.6](/filings/0001654954-26-007478.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001654954-24-013767.md) | not reported | [0.31](/filings/0001654954-25-005148.md) | [0.56](/filings/0001654954-25-009068.md) | [(2.46)](/filings/0001654954-25-012582.md) | not reported | [0.32](/filings/0001654954-26-004741.md) | [0.56](/filings/0001654954-26-007478.md) | [0.10](/filings/0001654954-25-012582.md) | not reported | [0.11](/filings/0001654954-26-004741.md) | [0.94](/filings/0001654954-26-007478.md) |
| Basic EPS | $ per share | [0.49](/filings/0001654954-24-013767.md) | not reported | [0.31](/filings/0001654954-25-005148.md) | [0.56](/filings/0001654954-25-009068.md) | [(2.47)](/filings/0001654954-25-012582.md) | not reported | [0.32](/filings/0001654954-26-004741.md) | [0.56](/filings/0001654954-26-007478.md) | [0.10](/filings/0001654954-25-012582.md) | not reported | [0.11](/filings/0001654954-26-004741.md) | [0.94](/filings/0001654954-26-007478.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [8.0](/filings/0001654954-25-002610.md) | not reported | not reported | [7.7](/filings/0001654954-24-013767.md) | [14.0](/filings/0001654954-26-002506.md) | [7.9](/filings/0001654954-25-005148.md) | [9.1](/filings/0001654954-25-009068.md) | [9.2](/filings/0001654954-25-012582.md) | [7.4](/filings/0001654954-26-007478.md) | [7.6](/filings/0001654954-26-004741.md) | [15.1](/filings/0001654954-26-007478.md) |
| Current assets | $m | [119](/filings/0001654954-23-013877.md) | [112](/filings/0001654954-25-002610.md) | [115](/filings/0001654954-24-005629.md) | [118](/filings/0001654954-24-010035.md) | [126](/filings/0001654954-24-013767.md) | [116](/filings/0001654954-26-002506.md) | [110](/filings/0001654954-25-005148.md) | [108](/filings/0001654954-25-009068.md) | [101](/filings/0001654954-25-012582.md) | [99.3](/filings/0001654954-26-007478.md) | [99.6](/filings/0001654954-26-004741.md) | [125](/filings/0001654954-26-007478.md) |
| Total assets | $m | [257](/filings/0001654954-23-013877.md) | [252](/filings/0001654954-25-002610.md) | [254](/filings/0001654954-24-005629.md) | [256](/filings/0001654954-24-010035.md) | [244](/filings/0001654954-24-013767.md) | [235](/filings/0001654954-26-002506.md) | [232](/filings/0001654954-25-005148.md) | [229](/filings/0001654954-25-009068.md) | [220](/filings/0001654954-25-012582.md) | [217](/filings/0001654954-26-007478.md) | [217](/filings/0001654954-26-004741.md) | [245](/filings/0001654954-26-007478.md) |
| Current liabilities | $m | [46.0](/filings/0001654954-23-013877.md) | [42.7](/filings/0001654954-25-002610.md) | [43.7](/filings/0001654954-24-005629.md) | [45.5](/filings/0001654954-24-010035.md) | [47.8](/filings/0001654954-24-013767.md) | [44.8](/filings/0001654954-26-002506.md) | [39.6](/filings/0001654954-25-005148.md) | [40.5](/filings/0001654954-25-009068.md) | [33.6](/filings/0001654954-25-012582.md) | [27.6](/filings/0001654954-26-007478.md) | [28.3](/filings/0001654954-26-004741.md) | [44.6](/filings/0001654954-26-007478.md) |
| Total liabilities | $m | [128](/filings/0001654954-23-013877.md) | [120](/filings/0001654954-25-002610.md) | [119](/filings/0001654954-24-005629.md) | [119](/filings/0001654954-24-010035.md) | [125](/filings/0001654954-24-013767.md) | [115](/filings/0001654954-26-002506.md) | [111](/filings/0001654954-25-005148.md) | [105](/filings/0001654954-25-009068.md) | [95.8](/filings/0001654954-25-012582.md) | [92.0](/filings/0001654954-26-007478.md) | [92.6](/filings/0001654954-26-004741.md) | [115](/filings/0001654954-26-007478.md) |
| Long-term debt | $m | [45.7](/filings/0001654954-23-013877.md) | [41.1](/filings/0001654954-25-002610.md) | [40.3](/filings/0001654954-24-005629.md) | [39.6](/filings/0001654954-24-010035.md) | [41.5](/filings/0001654954-24-013767.md) | [38.6](/filings/0001654954-26-002506.md) | [37.6](/filings/0001654954-25-005148.md) | [32.1](/filings/0001654954-25-009068.md) | [31.0](/filings/0001654954-25-012582.md) | [33.9](/filings/0001654954-26-007478.md) | [32.9](/filings/0001654954-26-004741.md) | [41.7](/filings/0001654954-26-007478.md) |
| Current portion of debt | $m | [3.0](/filings/0001654954-23-013877.md) | [2.9](/filings/0001654954-25-002610.md) | [2.9](/filings/0001654954-24-005629.md) | [2.9](/filings/0001654954-24-010035.md) | [3.2](/filings/0001654954-24-013767.md) | [3.6](/filings/0001654954-26-002506.md) | [4.0](/filings/0001654954-25-005148.md) | [4.3](/filings/0001654954-25-009068.md) | [4.3](/filings/0001654954-25-012582.md) | [0.0](/filings/0001654954-26-002506.md) | not reported | not reported |
| Shareholders' equity | $m | [129](/filings/0001654954-23-013877.md) | [132](/filings/0001654954-26-002506.md) | [135](/filings/0001654954-24-005629.md) | [136](/filings/0001654954-24-010035.md) | [119](/filings/0001654954-24-013767.md) | [121](/filings/0001654954-26-007478.md) | [121](/filings/0001654954-26-004741.md) | [124](/filings/0001654954-26-007478.md) | [124](/filings/0001654954-25-012582.md) | [125](/filings/0001654954-26-007478.md) | [125](/filings/0001654954-26-004741.md) | [130](/filings/0001654954-26-007478.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.6 d](/filings/0001654954-24-013767.md) | [7.4 d](/filings/0001654954-25-002610.md) | [2.8](/filings/0001654954-25-005148.md) | [8.4 d](/filings/0001654954-25-009068.md) | [(2.9) d](/filings/0001654954-25-012582.md) | [11.0 d](/filings/0001654954-26-002506.md) | [(1.8)](/filings/0001654954-26-004741.md) | [3.8 d](/filings/0001654954-26-007478.md) | [3.1 d](/filings/0001654954-25-012582.md) | [3.8 d](/filings/0001654954-26-002506.md) | [3.5](/filings/0001654954-26-004741.md) | [8.6 d](/filings/0001654954-26-007478.md) |
| Capital expenditure | $m | [2.1 d](/filings/0001654954-24-013767.md) | [1.5 d](/filings/0001654954-25-002610.md) | [1.7](/filings/0001654954-25-005148.md) | [1.1 d](/filings/0001654954-25-009068.md) | [4.8 d](/filings/0001654954-25-012582.md) | [2.1 d](/filings/0001654954-26-002506.md) | [0.8](/filings/0001654954-26-004741.md) | [0.8 d](/filings/0001654954-26-007478.md) | [0.0 d](/filings/0001654954-25-012582.md) | [2.3 d](/filings/0001654954-26-002506.md) | [0.9](/filings/0001654954-26-004741.md) | [0.6 d](/filings/0001654954-26-007478.md) |
| Dividends paid | $m | [0.7 d](/filings/0001654954-24-013767.md) | [0.7 d](/filings/0001654954-24-003010.md) | [0.7](/filings/0001654954-24-005629.md) | [0.7 d](/filings/0001654954-24-010035.md) | [0.7 d](/filings/0001654954-24-013767.md) | [0.7 d](/filings/0001654954-26-002506.md) | [0.7](/filings/0001654954-26-004741.md) | [0.7 d](/filings/0001654954-26-007478.md) | [0.7 d](/filings/0001654954-25-012582.md) | [0.7 d](/filings/0001654954-26-002506.md) | [0.7](/filings/0001654954-26-004741.md) | [0.7 d](/filings/0001654954-26-007478.md) |
| Share repurchases | $m | [0.2 d](/filings/0001654954-23-013877.md) | [0.5 d](/filings/0001654954-25-002610.md) | [0.2](/filings/0001654954-25-005148.md) | [0.2 d](/filings/0001654954-25-009068.md) | [1.4 d](/filings/0001654954-25-012582.md) | [1.1 d](/filings/0001654954-26-002506.md) | [1.4](/filings/0001654954-26-004741.md) | [0.7 d](/filings/0001654954-26-007478.md) | [0.9 d](/filings/0001654954-25-012582.md) | [0.8 d](/filings/0001654954-26-002506.md) | [0.4](/filings/0001654954-26-004741.md) | [0.4 d](/filings/0001654954-26-007478.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,223](/filings/0001654954-23-013877.md) | [6,223](/filings/0001654954-24-005629.md) | [6,233](/filings/0001654954-24-010035.md) | [6,217](/filings/0001654954-24-013767.md) | [6,255](/filings/0001654954-25-005148.md) | [6,259](/filings/0001654954-25-009068.md) | [6,229](/filings/0001654954-25-012582.md) | [6,147](/filings/0001654954-26-004741.md) | [6,121](/filings/0001654954-26-007478.md) | [6,083](/filings/0001654954-25-012582.md) | [6,049](/filings/0001654954-26-004741.md) | [6,030](/filings/0001654954-26-007478.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,017,558 at 2026-07-04, from the cover of the [10-Q filed 2026-08-11](/filings/0001654954-26-007478.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.